Article • The MR-INFORM trial
Seeking a first-line ischaemia test
Findings from a comparative outcome study have highlighted the benefits of using cardiovascular magnetic resonance imaging (CMR) perfusion imaging as a first-line ischaemia test in patients with moderate risk of coronary artery disease (CAD). The MR-INFORM (Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease) trial, which began in 2012 (results published in the New England…